OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Trial protocol
Highlighted
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Study Design
1276 Publications
found
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.
b
Investigational new drugs
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Early Blood-based Liquid Biopsy in Patients with Treatment-naïve Metastatic Adenocarcinoma of the Lung: A Case Series.
b
The Israel Medical Association journal : IMAJ
December 1, 2020
p
Cancer
c
Change patient management
Observational
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
b
Diabetologia
December 1, 2020
p
Diabetes
c
Guideline
Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model.
b
JAMA network open
December 1, 2020
p
Newborn Screening
c
Economics
Highlighted
Model
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
b
The Lancet. Oncology
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
b
The oncologist
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.
b
The Lancet. Infectious diseases
December 1, 2020
p
COVID-19
c
Clinical outcomes
Model
Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis.
b
Le infezioni in medicina
December 1, 2020
p
Cardiovascular Disease
c
Clinical outcomes
Meta-analysis
Biomarker-guided management of acute kidney injury.
b
Current opinion in critical care
December 1, 2020
p
Kidney Disease
c
Review
Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy.
b
The Journal of pediatrics
December 1, 2020
p
Newborn Screening
c
Economics
Model
Previous Page
1
…
43
44
45
46
47
…
128
Next Page
